Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial-Reference-Cited by-同舟云学术

Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial

Published:2020-12 Issue:6 Volume:50 Page:1513-1520
ISSN:0049-0172
Container-title:Seminars in Arthritis and Rheumatism
language:en
Short-container-title:Seminars in Arthritis and Rheumatism

Author:

Wang Yiwen,Zhao Zheng,Gao Dai^ORCID,Wang Hui,Liao Simin,Dong Chongya,Luo Gui,Ji Xiaojian,Li Yan,Wang Xiuru,Zhao Yurong,Li Kunpeng,Zhang Jie,Jin Jingyu,Zhang Yamei,Zhu Jian,Zhang Jianglin,Huang Feng

Funder

National Basic Research Program of China

Publisher

Elsevier BV

Subject

Anesthesiology and Pain Medicine,Rheumatology

Reference46 articles.

1. IgG4-related disease;Kamisawa;Lancet,2015

2. Consensus statement on the pathology of IgG4-related disease;Deshpande;Mod Pathol,2012

3. The clinical spectrum of IgG4-related disease;Brito-Zeron;Autoimmun Rev,2014

4. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease;Khosroshahi;Arthritis Rheumatol,2015

5. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation;Takayama;Am J Gastroenterol,2004

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurologic Manifestations of Rheumatologic Disorders;CONTINUUM: Lifelong Learning in Neurology;2024-08

2. The clinical outcomes and healthcare resource utilization in IgG4-related disease: a claims-based analysis of commercially insured adults in the United States;Rheumatology;2024-04-19

3. Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial;Annals of the Rheumatic Diseases;2024-01-12

4. Current and future advances in practice: IgG4-related disease;Rheumatology Advances in Practice;2024-01-01

5. Therapeutic Efficacy of B-Cell Depletion by Anti-CD19 CAR-T in a Mouse Model of IgG4-RD;2024